Passage Bio, Inc. (PASG)
NASDAQ: PASG · IEX Real-Time Price · USD
0.900
+0.010 (1.10%)
At close: Jul 19, 2024, 4:00 PM
0.873
-0.027 (-3.00%)
Pre-market: Jul 22, 2024, 7:12 AM EDT
Passage Bio Market Cap
Passage Bio has a market cap or net worth of $55.47 million as of July 22, 2024. Its market cap has increased by 12.74% in one year.
Market Cap
55.47M
Enterprise Value
-22.58M
1-Year Change
12.74%
Ranking
Category
Stock Price
$0.90
Market Cap Chart
Since February 28, 2020, Passage Bio's market cap has decreased from $932.40M to $55.47M, a decrease of -94.05%. That is a compound annual growth rate of -47.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 55.50M | 0.18% |
| Dec 29, 2023 | 55.40M | -26.43% |
| Dec 30, 2022 | 75.30M | -78.08% |
| Dec 31, 2021 | 343.60M | -70.49% |
| Dec 31, 2020 | 1.16B | 24.87% |
| Feb 28, 2020 | 932.40M | - |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anebulo Pharmaceuticals | 57.05M |
| Cytosorbents | 57.02M |
| LENSAR | 56.07M |
| CollPlant Biotechnologies | 55.70M |
| Rallybio | 55.54M |
| OKYO Pharma | 55.17M |
| Allurion Technologies | 54.98M |
| Immix Biopharma | 54.94M |